Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/115740

Beta release

Statistics of Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD (TM) study
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0700
2024-0800
2024-0900